The Gift of Sight Appeal was established with the aim of funding world-class research into the prevention and treatment of blindness. Age-related macular degeneration studies could also provide therapies for other blinding retinal diseases.
The Gift of Sight research team is dedicated to furthering our understanding of the causes and treatments for blinding eye diseases. Our adult ocular stem cell and gene therapy programmes are gaining momentum towards future therapies and treatments. With your support we aim to ensure vision into the future for those who are suffering today. Details of our most recent research papers can be found here.
Professor Andrew Lotery is leading a collaborative multi-centre Phase 3 study into the use of lampalizumab which it hoped will slow the progression of 'Dry' age-related macular degeneration. Please see our 'News & Events' page for further details.
If you have been diagnosed with eye disease and are likely to be making more visits to Southampton Eye Unit you may find our video interesting.
A recent International Study has revealed new genetic clues to Age-related Macular Degeneration. Please read the report here.